Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer

The platinum-based, two-drug, 3-week regimen is currently the main first-line chemotherapy program for the treatment of advanced squamous cell lung cancer. The aim of this phase II clinical study was to evaluate the efficacy and adverse events of the bi-weekly program of liposomal paclitaxel combine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Wei-Ze, Lin, Zhong, Wang, Si-Yang, Lv, Bao-Jun, Wang, Zhi-Hui, Xiao, Mei, Xu, Xiao-Lu, Peng, Pei-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395851/
https://www.ncbi.nlm.nih.gov/pubmed/30822722
http://dx.doi.org/10.1016/j.tranon.2019.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395851/
https://www.ncbi.nlm.nih.gov/pubmed/30822722
http://dx.doi.org/10.1016/j.tranon.2019.01.008

Ejemplares similares